camonsertib,Niraparib,Olaparib,Talazoparib
repare therapeutics,roche,gsk,astrazeneca,merck,pfizer
['camonsertib', 'repare therap', 'repare,(-prepare)']
$rptx repare therapeutics presents initial clinical data on camonsertib in combination with three parp inhibitors at the 2023 aacr annual meeting. more info: $xbi $ibb $xph $pph
Latest BioPharma/Biotech News. Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  https://t.co/lvTtwarrGT